Powered by
Tags
Clinical Trial Management & support services

Overview

Molecule2Market (M2M), established in February 2012, is a boutique CRO dedicated to the research and development of innovative medical treatments for the pharmaceutical, biotechnology and medical device industries. With an average of 20 plus years’ experience, our team members provide high quality services across all phases of clinical research and a broad range of therapeutic areas covering sites in Australia, New Zealand the USA.

M2M services cover the following clinical research activities:
• Project/ site feasibility
• Study start-up, monitoring and close out
• Project management
• Patient recruitment
• Local safety reporting
• Audit/ quality review
• Medical writing
• Local study sponsorship

M2M also offers the following services:
• Regulatory
• Data management/ statistics
• Medical monitoring
• Applying the Australian R&D Tax Incentive when conducting research in Australia

M2M is a proud member of AICROS, the Association of International Contract Research Organizations. AICROS is an alliance of local well established CROs covering Europe, Africa, Israel and India. This membership enables M2M to provide our clients with high quality clinical research services on a global scale.

Delegates

Anne_DeLuca_067_LowRes.jpg
Anne De Luca
Director & Co-Founder
Robin_Hansen_040_LowRes.jpg
Robin Hansen
Director & Co-Founder
George_Zafiris_highres-72693-scaled-1.jpg
George Zafiris
Director (US Office)
George_Zanfins-72782_300x222.jpg